Tilray Brands (2HQ0.DE) stock: Winston Score, insiders and Congress trades
Tilray Brands is a Canadian company that grows and sells cannabis products, including dried flower, oils, and edibles, to both medical patients and adult recreational consumers. It also owns a portfolio of alcoholic beverage brands, including several craft beers and spirits, which it sells mainly in the United States. Tilray is one of the largest cannabis companies in the world by revenue. Tilray makes money by selling cannabis products through licensed retailers and pharmacies in Canada, Germany, and other countries where medical or recreational cannabis is legal, and through its beverage alcohol business in the US. The company operates across North America and Europe, giving it broader geographic reach than most cannabis peers. However, Tilray has struggled to turn a profit, and its deeply negative operating margin signals that costs remain far higher than revenues — the key risk is whether cannabis markets can grow fast enough, and US federal legalization can progress far enough, to make the business sustainably profitable.
Winston Score: 23 out of 100, Weak
Weak fundamentals across most pillars.
- Quality: Weak (4/30)
- Growth: Good (11/20)
- Cash Flow: Weak (0/10)
- Stability: Good (5/10)
- Valuation: Data not available (0/10)
- Ownership: Weak (2/15)
Key Facts
Price: €3.21
Market Cap: €360M
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Exchange: Frankfurt Stock Exchange
Editorial rules set and reviewed by Felix Prehn, Economist and Editor. Figures are refreshed daily from Financial Modeling Prep and company filings; last refreshed 2026-10-05.

